Isolate | Patient | Date of Isolation | CFUa | GBS Most Abundant | Reduced FEV1 b | PExc * | ABx Required | Co-Infectionsd |
---|---|---|---|---|---|---|---|---|
1 | 1 | 1990 | 104 | N | N | Y | Y | HI |
2 | 2 | 2005 | 104 | N | N | N | – | PA |
3 | 3 | 1994 | 106 | N | Y | Y* | Y | MSSA, SM |
4 | 4 | 2013 | 106 | Equal | N | N | – | PA |
5 | 5 | 2012 | 106 | N | N | Y | Y | PA |
6 | 5 | −2012 | 104 | N | Y | N | – | PA |
7 | 5 | −2012 | 105 | N | N | N | – | PA |
8 | 5 | 2012 | 106 | Equal | N | N | – | PA |
9 | 5 | 2013 | N/A | Equal | Y | N | – | PA |
10 | 5 | 2013 | 105 | N | N | N | N | PA |
11 | 5 | 2013 | 106 | N | N | Y | Y | PA |
12 | 5 | 2013 | 107 | Y | Y | Y* | Y | PA |
13 | 6 | 1992 | 105 | N | N | N | – | PA, MSSA |
14 | 7 | 1986 | 104 | N | N/A | Y* | Y | PA |
15 | 7 | 1986 | N/A | Y | N | N | – | – |
16 | 7 | 1986 | N/A | Y | N | N | – | – |
17 | 7 | 1987 | 106 | N | N | N | – | HI |
18 | 7 | 1987 | 105 | N | Y | N | – | O |
19 | 7 | 1987 | 105 | N/A | N | N | – | N/A |
20 | 7 | 1987 | 104 | N | N | N | – | – |
21 | 8 | 2011 | 105 | Equal | N | N | – | MSSA |
22 | 9 | 2013 | 106 | Y | N | N | – | – |
23 | 10 | 2013 | 106 | Equal | N | N | – | MSSA |
24 | 11 | 1990 | 105 | N | N | Y | Y | PA |
25 | 11 | 1991 | 106 | Y | N | N | – | PA |
26 | 11 | 1992 | 106 | Equal | N | N | – | PA |
27 | 11 | 1992 | 104 | Equal | N | Y | Y | PA |
28 | 11 | 1993 | 108 | Y | N | Y | Y | PA |
29 | 11 | 1993 | 107 | N | N | N | – | PA, O |
30 | 11 | 1993 | 107 | Equal | N | N | – | PA, O |